EIF2AK2 and viral infectious disease: Given that both viral infection [24,58] and arsenite treatment [66] activate PKR and induce SG formation, and arsenite activates PKR by inducing PACT to bind PKR [65,66], we examined the mechanism by which ORF57 inhibits arsenite/poly I:C activation of PKR.